SCHEMBL7180664

SCHEMBL7180664

CCCCOc1ccc(C)c(OCCCC)c1C=CC(=O)c1ccc(N)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.46
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
PDE4D Q08499 1/20 0.45
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
KRAS P01116 1/20 0.44
BCHE P06276 5/20 0.42
DPP4 P27487 1/20 0.41
PTPN1 P18031 1/20 0.41
ACHE P22303 3/20 0.41
NPC1 O15118 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CTSL P07711 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187979 0.94 CA1 (0.45) ABCG2LMNACA1CA2KRAS
SCHEMBL7186152 0.89 ABCG2 (0.59) ABCG2LMNACYP1A2TSHRCYP2C19
SCHEMBL7178891 0.88 ABCG2 (0.44) ABCG2LMNACYP1A2CYP3A4CYP2C9
SCHEMBL7177660 0.87 CYP1B1 (0.47) ABCG2LMNACYP1A2CYP3A4CA1
SCHEMBL7177657 0.87 CYP1B1 (0.47) ABCG2LMNACYP1A2CYP3A4CA1
SCHEMBL7180071 0.87 ABCG2 (0.43) ABCG2LMNACYP1A2CYP3A4CYP2C9
SCHEMBL7184886 0.86 ABCG2 (0.45) ABCG2BCHEDPP4PTPN1ACHE
SCHEMBL7185926 0.86 ABCG2 (0.45) ABCG2LMNABCHEDPP4PTPN1
SCHEMBL7184728 0.85 ABCG2 (0.56) ABCG2LMNACYP1A2CYP3A4CYP2C9
SCHEMBL7186366 0.85 PTPN1 (0.43) ABCG2LMNACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed